1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Orphan Drug Market Dynamics and Patient Recruitment Best Practices

Orphan Drug Market Dynamics and Patient Recruitment Best Practices

  • February 2015
  • -
  • Industry Standard Research
  • -
  • 68 pages

Summary

Table of Contents

Report Overview

The recruitment of patients for orphan drug trials adds levels of complexity to the already difficult process of patient recruitment. ISR sought the opinions of individuals with extensive experience with orphan drug trial recruitment in order to understand the most and least effective practices in orphan drug trial patient recruitment, how orphan drug trials are organized, the regulatory guidelines surrounding orphan drug trial recruitment, and ultimately what to expect for the future in terms of orphan drug trials.
ISR also analyzes key trial metrics, such as number and phase of orphan drug trials, outsourcing trends, study type, source of funding, projected vs. actual trial lengths, and enrollment figures for ongoing orphan drug/rare disease trials to provide a comprehensive look at the orphan drug market.

Report Scope

What you will learn in this report:

- The most and least effective practices in orphan drug trial patient recruitment
- How orphan drug trials are typically organized within a company’s structure
- The regulatory guidelines surrounding orphan drug trial recruitment
- What to expect for the future in terms of orphan drug trials
- How individual companies perceive and handle orphan drug trials (number of
orphan drug trials, outsourcing trends, deadlines met, etc.)
- Current orphan drug trial metrics, such as the phase, source of funding, study type, length of trial, projected vs. actual trial lengths, and enrollment figures
- Best practices for:
- Marketing CRO orphan drug services
- Direct recruiting practices
- Involving Key Opinion Leaders
- Patient advocacy groups and social media
- Sponsor methods for CRO selection

How you can use this report:

-Anticipate potential problems in orphan disease patient recruitment in order to
reduce trial delays
- Understand regulatory guidelines for orphan drug trials and the difficulties these
guidelines pose
- Benchmark your company’s orphan drug trial recruiting structure to those of other
companies outlined in the report
- Understand the bigger picture of the orphan drug recruitment process and what to
expect in the future




Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


Download Unlimited Documents from Trusted Public Sources

Respiratory Treatment Market in the US

  • April 2017
    8 pages
  • Respiratory Tre...  

  • United States  

View report >

Antipsychotic Market in the Netherlands

  • April 2017
    9 pages
  • Antipsychotic  

  • Netherlands  

View report >

Therapy Market in the US

  • April 2017
    44 pages
  • Therapy  

    Serotonin Speci...  

    Antidepressant  

  • United States  

View report >

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.